Constitutional Showdown Looms as States Prepare Legal Challenge to Trump's AI Preemption Order

# Constitutional Showdown Looms as States Prepare Legal Challenge to Trump's AI Preemption Order

A rare bipartisan coalition of states is on a collision course with the Trump administration over who controls the regulation of artificial intelligence in health insurance—setting the stage for a constitutional battle that could reshape the balance of federal and state power in the emerging AI economy.

The Current Standoff

According to Articles 1-7 and 10-11, President Trump issued an executive order in December 2025 seeking to preempt most state efforts to regulate AI, arguing that "United States AI companies must be free to innovate without cumbersome regulation" and that "excessive State regulation thwarts this imperative." The order frames AI development as a matter of national security, describing it as "a race with adversaries for supremacy" in a "technological revolution." Yet states across the political spectrum are defying this federal directive. At least six states—Arizona, Maryland, Nebraska, Texas, Illinois, and California—have already enacted legislation restricting AI use in health insurance. The coalition includes traditional conservative strongholds like Texas and Nebraska alongside progressive states like California and Maryland, creating what Article 1 describes as "the rare policy question that unites Republican Gov. Ron DeSantis of Florida and the Democratic-led Maryland government against President Donald Trump." Most notably, even California Governor Gavin Newsom—typically a Trump opponent—finds himself aligned with the administration on this issue, highlighting how AI regulation is "scrambling traditional partisan lines."

Key Trends and Signals

Several critical patterns emerge from the current landscape: **State Momentum is Accelerating**: The legislative activity shows no signs of slowing. Rhode Island legislators plan to reintroduce legislation in 2026 after narrowly failing last year, while North Carolina has introduced bills requiring that AI not be "the sole basis of a coverage decision." This represents a second wave of state action following the initial 2024-2025 bills. **Bipartisan Consumer Protection Focus**: States are united by constituent concerns about health insurance denials driven by opaque AI systems. Insurance regulation has historically been a state domain under the McCarran-Ferguson Act, giving states a strong legal foundation for resistance. **Medicare as Federal Proving Ground**: The Trump administration is simultaneously pushing AI integration into Medicare's prior authorization process, creating a natural experiment that will produce data points both sides can use in coming debates. **Tech Industry Stakes**: The executive order's language suggests significant pressure from AI companies seeking regulatory certainty and a single national framework rather than a patchwork of state requirements.

What Happens Next

### Legal Challenge (High Confidence, 3-6 Months) Multiple states will file coordinated legal challenges to Trump's executive order, likely led by attorneys general from states that have already passed AI insurance legislation. The lawsuit will argue that the executive order exceeds presidential authority and violates principles of federalism enshrined in the Tenth Amendment. Maryland, Texas, and Illinois are probable lead plaintiffs given their existing statutory frameworks. The challenge will invoke the McCarran-Ferguson Act of 1945, which explicitly reserves insurance regulation to the states unless Congress passes legislation specifically intended to preempt state insurance laws. An executive order alone cannot override this statutory framework. ### Congressional Battle Lines Form (Medium Confidence, 2-4 Months) Congressional Republicans will face internal division between tech-industry aligned members supporting federal preemption and states' rights advocates backing their governors. Expect introduction of competing bills: one establishing federal AI standards that preempt state laws, and another codifying state authority to regulate AI in insurance. The Senate, where each state has equal representation regardless of population, will likely prove more sympathetic to state autonomy arguments than the House. ### High-Profile Insurance Denials Fuel Public Pressure (High Confidence, Ongoing) Media coverage will intensify around individual cases of AI-driven insurance denials, particularly involving cancer treatments, rare diseases, or children's healthcare. These stories will provide political ammunition for state regulators and legislators, making it politically costly for federal officials to be seen as siding with insurers over patients. The Medicare AI pilot program will likely produce controversial cases that become fodder for both supporters and critics. ### Industry Fragmentation (Medium Confidence, 6-12 Months) Health insurers will find themselves caught between federal encouragement to deploy AI and state restrictions. Larger national insurers may lobby for federal preemption to avoid compliance costs, while regional insurers aligned with state regulators may actually prefer state-level rules that could disadvantage national competitors. Tech companies providing AI tools to insurers will face difficult decisions about whether to develop state-specific compliance features or limit their markets. ### Interim Compromise Emerges (Low-Medium Confidence, 9-18 Months) If litigation proceeds slowly and congressional gridlock persists, federal regulators may seek an informal compromise: establishing voluntary federal AI guidelines for insurers while tacitly allowing states to maintain oversight. This would mirror the current dual federal-state insurance regulatory framework. Alternatively, Congress could pass narrow legislation requiring transparency and human review in AI-driven coverage decisions—standards both federal AI boosters and state regulators could accept—while leaving enforcement to states.

The Broader Implications

This conflict transcends health insurance. The outcome will establish precedent for AI regulation across sectors from employment to criminal justice to lending. If Trump's preemption order survives legal challenge, it could dramatically limit state power to regulate emerging technologies. If states prevail, it ensures continued regulatory fragmentation that AI companies have warned could hamper American competitiveness. The peculiar political realignment—with DeSantis and Maryland Democrats aligned against Trump and Newsom—suggests this debate cuts deeper than partisan politics to fundamental questions about technological governance, consumer protection, and federalism in the 21st century. The next six months will likely determine whether AI regulation follows the decentralized state-led model that has governed insurance for 80 years, or whether the technology's national security implications justify a unprecedented assertion of federal control.